SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

EU Panel Recommends Roche’s Gazyva for Lupus Approval

The CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for systemic lupus erythematosus.

Story updates

11:34:12 AM UTC
SquawkNews
Positive recommendation is based on phase III ALLEGORY study data showing Gazyva/Gazyvaro significan

Related stories